In November 2008, C&O participated in the cefditoren licensing meeting organized by Meiji, a leading food and drug company in Japan, held in Tokyo, Japan. C&O has been Meiji’s designated distributor since January 2008 for the sale of its new generation cephalosporin, Meiact, in China.